Immutep notches upward on first lung cancer patient dosing
Immutep Ltd (ASX:IMM) has dosed the first patient of its Phase 3…
Immutep Limited (ASX:IMM)
About Immutep Limited
Key Information
IMM In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 25/03/2025 | Price Sensitive PS First patient dosed in phase 3 TACTI-004 lung cancer trial | 273.27KB | 7.1K |
| 20/03/2025 | TACTI-004 trial in progress poster to be presented at ELCC | 234.63KB | 952 |
| 26/02/2025 | Price Sensitive PS Half Yearly Report and Accounts | 888.77KB | 12K |
| 06/02/2025 | Notification of cessation of securities - IMM | 12.74KB | 4.1K |
| 05/02/2025 | Immutep Corporate Presentation | 3.37MB | 868 |
| 31/01/2025 | Price Sensitive PS Immutep Quarterly Activities Report and Appendix 4C | 400.18KB | 10K |
| 22/01/2025 | Enrolment completed for Ph II trial in Soft Tissue Sarcoma | 97.18KB | 640 |
| 06/01/2025 | Patient Enrolment Completed for INSIGHT-003 | 262.36KB | 1.9K |